Background: Catheter and cryoballoon ablation are established treatments for atrial fibrillation. Frequently, substrate modification of the left atrium is performed in patients with persistent AF or evidence of left atrial adverse remodeling. We compared one year outcomes of AF ablation with substrate modification utilizing radiofrequency catheter ablation (RFA) compared to a combination of cryoballoon ablation with radiofrequency catheter ablation (HAFA). Methods: Ablation for persistent AF was performed using stand-alone catheter ablation (RFA group, n=31) or cryoballoon for pulmonary vein isolation with RFA catheter ablation for substrate modification (HAFA group, n=21) and procedural and clinical outcomes were analyzed. Pulmonary vein isolation and LA substrate modification including creation of left atrial ablation lines and/or CFAEs was performed in all patients. Patients were followed for up to one year. A three- month blinding window was applied for analysis. Results: Clinical characteristics were similar between groups. Total procedure (244.15±64.7 vs 235.5±54.6, p=0.6) and fluoroscopy time (37±15.4 vs 29.5±15.7, p=0.96) were not different between the HAFA and RFA groups, respectively. Periprocedural complications were similar among groups. AF free survival was not significantly different between Conclusions: Combined cryoballoon and catheter ablation for LA substrate modification (HAFA) has similar safety and efficacy compared to stand-alone catheter ablation for persistent AF. Recurrent atrial flutter is more frequently observed after cryoballoon ablation for persistent AF.
Background: Catheter and cryoballoon ablation are established treatments for atrial fibrillation. Frequently, substrate modification of the left atrium is performed in patients with persistent AF or evidence of left atrial adverse remodeling. We compared one year outcomes of AF ablation with substrate modification utilizing radiofrequency catheter ablation (RFA) compared to a combination of cryoballoon ablation with radiofrequency catheter ablation (HAFA). Methods: Ablation for persistent AF was performed using stand-alone catheter ablation (RFA group, n=31) or cryoballoon for pulmonary vein isolation with RFA catheter ablation for substrate modification (HAFA group, n=21) and procedural and clinical outcomes were analyzed. Pulmonary vein isolation and LA substrate modification including creation of left atrial ablation lines and/or CFAEs was performed in all patients. Patients were followed for up to one year. A three- month blinding window was applied for analysis. Results: Clinical characteristics were similar between groups. Total procedure (244.15±64.7 vs 235.5±54.6, p=0.6) and fluoroscopy time (37±15.4 vs 29.5±15.7, p=0.96) were not different between the HAFA and RFA groups, respectively. Periprocedural complications were similar among groups. AF free survival was not significantly different between Conclusions: Combined cryoballoon and catheter ablation for LA substrate modification (HAFA) has similar safety and efficacy compared to stand-alone catheter ablation for persistent AF. Recurrent atrial flutter is more frequently observed after cryoballoon ablation for persistent AF.
Authors: Arthur Garan; Amin Al-Ahmad; Teresa Mihalik; Catherine Cartier; Lea Capuano; David Holtan; Christopher Song; Munther K Homoud; Mark S Link; N A Mark Estes; Paul J Wang Journal: J Interv Card Electrophysiol Date: 2006-03 Impact factor: 1.900
Authors: Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano Journal: Europace Date: 2006-09 Impact factor: 5.214
Authors: Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady Journal: Circulation Date: 2002-03-05 Impact factor: 29.690
Authors: Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Claude S Elayi; Atul Verma; Luigi Di Biase; Chi Keong Ching; Dimpi Patel; Conor Barrett; David Martin; Bai Rong; Tamer S Fahmy; Yaariv Khaykin; Richard Hongo; Steven Hao; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; Domenico Potenza; Raffaele Fanelli; Raimondo Massaro; Mauricio Arruda; Robert A Schweikert; Andrea Natale Journal: Heart Rhythm Date: 2008-09-17 Impact factor: 6.343
Authors: Gunnar Klein; Hanno Oswald; Ajmal Gardiwal; Ulrich Lüsebrink; Christoph Lissel; Hong Yu; Helmut Drexler Journal: Heart Rhythm Date: 2008-02-16 Impact factor: 6.343
Authors: Fiorenzo Gaita; Domenico Caponi; Marco Scaglione; Antonio Montefusco; Antonella Corleto; Fernando Di Monte; Daniele Coin; Paolo Di Donna; Carla Giustetto Journal: Circ Arrhythm Electrophysiol Date: 2008-10